Evidence map›Paper›PMID 40672767›Full record

ArticleSovremennye tekhnologii v meditsine2025

The Development of Inner Ear Membrane Analog for Experimental Otorhinolaryngology.

A A Riabinin, O S Rogovaya, A I Kryukov, N L Kunelskaya, E S Yanyushkina, V V Mischenko, M M Ilyin, E A Shershunova, V V Voyevodin, S V Nebogatkin and 2 more

Abstract read
In one paragraph

Article in Sovremennye tekhnologii v meditsine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A A RiabininResearch Engineer, Laboratory of Cell Biology; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 26 Vavilov St., Moscow, 119334, Russia.
O S RogovayaSenior Researcher, Laboratory of Cell Biology; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 26 Vavilov St., Moscow, 119334, Russia.
A I KryukovProfessor, Corresponding Member of the Russian Academy of Sciences, Director; Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Bldg. 2, 18A Zagorodnoye Shosse, Moscow, 117152, Russia.
N L KunelskayaProfessor, Deputy Director for Science; Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Bldg. 2, 18A Zagorodnoye Shosse, Moscow, 117152, Russia.
E S YanyushkinaLeading Researcher, Research Department of Surdology and Pathology of the Inner Ear; Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Bldg. 2, 18A Zagorodnoye Shosse, Moscow, 117152, Russia.
V V MischenkoSenior Researcher, Research Department of the Ear Microsurgery; Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Bldg. 2, 18A Zagorodnoye Shosse, Moscow, 117152, Russia.
M M IlyinResearcher, Laboratory of Stereochemistry of Sorption Processes; Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences, Bldg. 1, 18A Vavilov St., Moscow, 119334, Russia.
E A ShershunovaHead of the Laboratory of High Power Pulsed Technology; Institute of Electrophysics and Electric Power of the Russian Academy of Sciences, Litera A, 18 Dvortsovaya Naberezhnaya, Saint Petersburg, 191181, Russia.
V V VoyevodinSenior Researcher, Laboratory of Electrodynamic Systems; Institute of Electrophysics and Electric Power of the Russian Academy of Sciences, Litera A, 18 Dvortsovaya Naberezhnaya, Saint Petersburg, 191181, Russia.
S V NebogatkinHead of the Laboratory of Applied Electrophysical Research; Institute of Electrophysics and Electric Power of the Russian Academy of Sciences, Litera A, 18 Dvortsovaya Naberezhnaya, Saint Petersburg, 191181, Russia.
K I PomanovEngineer, Laboratory of High Power Pulsed Technology; Institute of Electrophysics and Electric Power of the Russian Academy of Sciences, Litera A, 18 Dvortsovaya Naberezhnaya, Saint Petersburg, 191181, Russia.
E A VorotelyakProfessor, Corresponding Member of the Russian Academy of Sciences, Head of the Laboratory of Cell Biology; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 26 Vavilov St., Moscow, 119334, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological part of the study: Several substrate options were tested to create the mRWM, including 2 variants of Viscoll collagen membranes (IMTEK, Russia) and a multi-component G-Derm membrane (G-DERM, Russia). In the first variant, only HaCaT epithelial cells were seeded on the membranes, and in the second variant, primary human dermal fibroblasts were seeded together with HaCaT epithelial cells (sequential application). The obtained mRWM were evaluated by morphological criteria using histochemical methods. As a result, the decision was made to use mRWM constructed on Viscoll membranes with the inclusion of both primary fibroblasts and human epithelial cells. Technical part of the study: A series of scientific experiments has been performed on the obtained mRWM aimed at studying the permeability and developing modes of electrophysical action on this biological barrier while maintaining its morphological and functional integrity and ensuring accelerated passage of dexamethasone through it. To accelerate the passage of dexamethasone across the mRWM, the electrophysical system initiated targeted iontophoresis of negatively charged dexamethasone molecules in parallel with electroporation of cell membranes in the sample. After the exposure, the residual viability of mRWM was assessed by histochemical staining with calcein and propidium iodide. The change in dexamethasone concentration after passage across the mRWM was assessed using a highly sensitive chromatograph. Conclusion: During the optimization of the mRWM fabrication protocol and the selection of suitable substrate components and cellular material, the model based on a thin Viscoll collagen membrane has been chosen as a substrate and primary human dermal fibroblasts and epithelial cells of the HaCaT line as a cellular material. The obtained experimental samples of mRWM represent a semipermeable membrane with living cells on the surface and are an alternative analog of the native structure, reproducing its geometric and morphofunctional characteristics. In addition, there has been demonstrated a method of using the for preclinical studies of electrophysical devices designed for accelerated passage of target substances through this membrane using electroporative and iontophoretic effects.

Indexed as

DexamethasoneMembranes, ArtificialRound Window, EarEpithelial CellsFibroblastsHumansDexamethasoneMembranes, Artificialhuman fibroblastskeratinocytesneurosensory bradyacusiapassive diffusion of dexamethasoneround window membraneround window membrane model

Identifiers

PMID40672767
PMCPMC12261290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.